EXTON, PA. (PRWEB) APRIL 23, 2021 Megna Health announced today that its Rapid COVID-19 IgM/IgG Test, previously authorized for use under the U.S. Food and Drug Administration (FDA) Emergency Use Authorization, is now available for Point of Care Settings. The test Read more…
EXTON, PA. September 28, 2020. Megna Health, a medical technology company based in Exton, PA, announced today that its Rapid COVID-19 Antigen Kit has been CE certified for European market. Megna Health’s Rapid COVID-19 Antigen Test detects is a lateral Read more…
Exton, PA, September 2, 2020. Megna Health, a medical technology company, announced today that its Rapid COVID-19 IgG and IgM Antibody Test has been CE certified for European market. CE certification (CE Mark) is the approval process of marketing medical Read more…
Megna Health, a medical technology company focused on the development and manufacturing of diagnostic and healthcare products, announced today that the Company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Rapid COVID-19 Read more…
Exton, PA, July 13, 2020 Megna Health, a medical technology company based in Exton, PA, announces results from independent validation of its Rapid COVID-19 Antibody IgG / IgM Test by NIH / NCI (National Cancer Institute) coordinated by FDA. Results Read more…
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.